Search results
New Trials in Prostate Cancer: Could Your Patient Benefit?
Medscape· 23 hours agoPerhaps one of your patients could benefit from a clinical trial that has recently opened in ...
Men on hair-loss drug warned of sexual and psychiatric side effects
The Telegraph via Yahoo News· 9 hours agoIt has also ordered suppliers of finasteride to now include a patient alert card in packs of the ...
Astellas' XTANDI™ (Enzalutamide) Granted European Commission Approval for Use in Additional...
KOLR - KSFX Ozarks· 6 days agoXTANDI is now the first and only novel hormone therapy available for the treatment of high-risk biochemical recurrent non-metastatic hormone-sensitive prostate cancer ...
King Charles set for return to public duty as Harry plans May return to UK: Live
The Independent via Yahoo News· 3 hours agoThe 75-year-old British monarch will slowly ease back into public life after a three-month break to...
Is the FDA Pausing More Cancer Trials? It's Hard to Tell
Medscape· 6 days agoIs the FDA Pressing Pause on More Cancer Trials? In October, the US Food and Drug Administration...
These Are the Drugs America Is Running Short On
247wallst.com· 11 hours agoDrug shortages in America are the result of supply line challenges, profit-based operations, and company closures.
Q&A: Harnessing the power of the immune system to combat cancer
Digital Journal· 7 hours agoImmunotherapy promises to deliver significant results in the battle against different forms of ...
Why Big Pharma Is Following Novartis' Lead In A $25 Billion Market
Investor's Business Daily· 5 days agoThe Swiss drugmaker's success has caught Big Pharma's attention, sparking an M&A spree that sent...
King Charles: What kind of cancer treatment is available to him - and what impact could it have
The Independent via Yahoo News· 3 days agoThe drugs seek to disrupt the way cancer cells grow and drive but can also damage some of the health...
AstraZeneca (AZN) to Report Q1 Earnings: Here's What to Expect
Zacks via Yahoo Finance· 7 days agoA phase III registrational study is expected to begin in 2025. For the acquisition, AstraZeneca...